lobbying_activities: 3383859

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3383859	da744348-7bb3-43bb-87ec-3c881c439f25	Q2	LMH STRATEGIC SOLUTIONS	401108183	GLAXOSMITHKLINE LLC	2025	second_quarter	PHA	Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2025-07-15T21:05:09-04:00